Amoxycillin Trihydrate IP (equivalent to Anhydrous Amoxycillin) + Diluted Potassium Clavulanate IP (equivalent to Clavulanic Acid)
Indications listed are general to the category. Specific use should be as per physician's clinical assessment.
All packaging conforms to Schedule M GMP standards of the Drugs & Cosmetics Act, 1940.
Crawlable clinical insights about Rite-625 Tablet for search queries and virtual healthcare guides.
Rite-625 Tablet is a professionally formulated Tablet belonging to the Antibiotics therapeutic class. It is primarily used for respiratory infections, soft tissue bacterial infections, and ear/nose/throat conditions, under strict guidelines of registered medical professionals.
The active composition of Rite-625 Tablet consists of Amoxycillin Trihydrate IP (equivalent to Anhydrous Amoxycillin): 500 mg, Diluted Potassium Clavulanate IP (equivalent to Clavulanic Acid): 125 mg. This blend meets exact pharmacopoeia quality benchmarks (IP/BP/USP) to deliver optimal safety and performance.
Store Rite-625 Tablet in a cool, dry place away from direct sunlight. Maintain temperatures in accordance with GMP guidelines. Since this is a prescription medication, do not self-medicate and consult a licensed physician.